265 related articles for article (PubMed ID: 32531395)
21. Development of nano-carriers for
Askarizadeh A; Badiee A; Khamesipour A
Expert Opin Drug Deliv; 2020 Feb; 17(2):167-187. PubMed ID: 31914821
[No Abstract] [Full Text] [Related]
22. A Novel Mucosal Adjuvant System for Immunization against Avian Coronavirus Causing Infectious Bronchitis.
Chandrasekar SS; Kingstad-Bakke B; Wu CW; Suresh M; Talaat AM
J Virol; 2020 Sep; 94(19):. PubMed ID: 32669327
[TBL] [Abstract][Full Text] [Related]
23. Nano and Microparticles as Potential Oral Vaccine Carriers and Adjuvants Against Infectious Diseases.
Jazayeri SD; Lim HX; Shameli K; Yeap SK; Poh CL
Front Pharmacol; 2021; 12():682286. PubMed ID: 34149426
[TBL] [Abstract][Full Text] [Related]
24. Recent developments in adjuvants for vaccines against infectious diseases.
O'Hagan DT; MacKichan ML; Singh M
Biomol Eng; 2001 Oct; 18(3):69-85. PubMed ID: 11566599
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and characterization of an octaarginine functionalized graphene oxide nano-carrier for gene delivery applications.
Imani R; Emami SH; Faghihi S
Phys Chem Chem Phys; 2015 Mar; 17(9):6328-39. PubMed ID: 25650242
[TBL] [Abstract][Full Text] [Related]
26. Archaeal lipid vaccine adjuvants for induction of cell-mediated immunity.
Haq K; Jia Y; Krishnan L
Expert Rev Vaccines; 2016 Dec; 15(12):1557-1566. PubMed ID: 27276183
[TBL] [Abstract][Full Text] [Related]
27. Mesoporous silica nanoparticles as antigen carriers and adjuvants for vaccine delivery.
Mody KT; Popat A; Mahony D; Cavallaro AS; Yu C; Mitter N
Nanoscale; 2013 Jun; 5(12):5167-79. PubMed ID: 23657437
[TBL] [Abstract][Full Text] [Related]
28. An immunopotentiator, ophiopogonin D, encapsulated in a nanoemulsion as a robust adjuvant to improve vaccine efficacy.
Tong YN; Yang LY; Yang Y; Song Z; Peng LS; Gao JN; Zeng H; Zou QM; Sun HW; Mao XH
Acta Biomater; 2018 Sep; 77():255-267. PubMed ID: 30031164
[TBL] [Abstract][Full Text] [Related]
29. Graphene oxide: A growth factor delivery carrier to enhance chondrogenic differentiation of human mesenchymal stem cells in 3D hydrogels.
Zhou M; Lozano N; Wychowaniec JK; Hodgkinson T; Richardson SM; Kostarelos K; Hoyland JA
Acta Biomater; 2019 Sep; 96():271-280. PubMed ID: 31325577
[TBL] [Abstract][Full Text] [Related]
30. Chitosan, N,N,N-trimethyl chitosan (TMC) and 2-hydroxypropyltrimethyl ammonium chloride chitosan (HTCC): The potential immune adjuvants and nano carriers.
Zhao J; Li J; Jiang Z; Tong R; Duan X; Bai L; Shi J
Int J Biol Macromol; 2020 Jul; 154():339-348. PubMed ID: 32184144
[TBL] [Abstract][Full Text] [Related]
31. Application of graphene oxide in tumor targeting and tumor therapy.
Zhang J; Yang Y; Li K; Li J
J Biomater Sci Polym Ed; 2023 Dec; 34(18):2551-2576. PubMed ID: 37768314
[TBL] [Abstract][Full Text] [Related]
32. Iron nanoparticles as novel vaccine adjuvants.
Behzadi M; Vakili B; Ebrahiminezhad A; Nezafat N
Eur J Pharm Sci; 2021 Apr; 159():105718. PubMed ID: 33465476
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive Review on Graphene Oxide for Use in Drug Delivery System.
Daniyal M; Liu B; Wang W
Curr Med Chem; 2020; 27(22):3665-3685. PubMed ID: 30706776
[TBL] [Abstract][Full Text] [Related]
34. Flagellin as a vaccine adjuvant.
Cui B; Liu X; Fang Y; Zhou P; Zhang Y; Wang Y
Expert Rev Vaccines; 2018 Apr; 17(4):335-349. PubMed ID: 29580106
[TBL] [Abstract][Full Text] [Related]
35. Chitosan-Functionalized Graphene Oxide as a Potential Immunoadjuvant.
Yan T; Zhang H; Huang D; Feng S; Fujita M; Gao XD
Nanomaterials (Basel); 2017 Mar; 7(3):. PubMed ID: 28336893
[TBL] [Abstract][Full Text] [Related]
36. Commonly Used Adjuvant Human Vaccines: Advantages and Side Effects.
Villarreal R; Casale TB
J Allergy Clin Immunol Pract; 2020 Oct; 8(9):2953-2957. PubMed ID: 32360184
[TBL] [Abstract][Full Text] [Related]
37. Vaccination with toxofilin DNA in combination with an alum-monophosphoryl lipid A mixed adjuvant induces significant protective immunity against Toxoplasma gondii.
Song P; He S; Zhou A; Lv G; Guo J; Zhou J; Han Y; Zhou H; Hao Z; Cong H
BMC Infect Dis; 2017 Jan; 17(1):19. PubMed ID: 28056837
[TBL] [Abstract][Full Text] [Related]
38. Mincle and STING-Stimulating Adjuvants Elicit Robust Cellular Immunity and Drive Long-Lasting Memory Responses in a Foot-and-Mouth Disease Vaccine.
Lee MJ; Jo H; Shin SH; Kim SM; Kim B; Shim HS; Park JH
Front Immunol; 2019; 10():2509. PubMed ID: 31736952
[TBL] [Abstract][Full Text] [Related]
39. Recent advances on chitosan as an adjuvant for vaccine delivery.
Dmour I; Islam N
Int J Biol Macromol; 2022 Mar; 200():498-519. PubMed ID: 34973993
[TBL] [Abstract][Full Text] [Related]
40. Advances and Potential Applications of Chitosan Nanoparticles as a Delivery Carrier for the Mucosal Immunity of Vaccine.
Li D; Fu D; Kang H; Rong G; Jin Z; Wang X; Zhao K
Curr Drug Deliv; 2017; 14(1):27-35. PubMed ID: 27494157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
